Stryker (SYK) EBITDA Margin (2009 - 2026)
Stryker (SYK) reported EBITDA Margin of 15.55% for Q1 2026, up 128.0% year-over-year from 6.82% in Q1 2025, and down 38.2% on a QoQ basis from 25.16% in Q4 2025.
Stryker (SYK) has 18 years of EBITDA Margin data on file, last reported at 15.55% in Q1 2026.
- Quarterly EBITDA Margin rose 128.0% year-over-year to 15.55% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 19.74% (up 443.0% YoY) and the FY2025 annual result came in at 19.47%, up 314.0% from the prior year.
- EBITDA Margin declined to 15.55% in Q1 2026 per SYK's latest filing, from 25.16% in the prior quarter.
- Across five years, EBITDA Margin topped out at 25.16% in Q4 2025 and bottomed at 9.03% in Q4 2024.
- The 5-year median for EBITDA Margin is 18.48% (2025), against an average of 17.38%.
- The widest annual swing landed in 2024, when EBITDA Margin plunged 1259 bps; it then soared 1613 bps in 2025.
- Tracing SYK's EBITDA Margin over 5 years: stood at 15.65% in 2022, then soared by 38 bps to 21.62% in 2023, then plunged by 58 bps to 9.03% in 2024, then jumped by 179 bps to 25.16% in 2025, then slumped by 38 bps to 15.55% in 2026.
- Per Business Quant, the three latest SYK EBITDA Margin figures stand at 15.55% (Q1 2026), 25.16% (Q4 2025), and 18.74% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 17.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.55% |
| Dec 31, 2025 | 25.16% |
| Sep 30, 2025 | 18.74% |
| Jun 30, 2025 | 18.48% |
| Mar 31, 2025 | 14.27% |
| Dec 31, 2024 | 9.03% |
| Sep 30, 2024 | 19.75% |
| Jun 30, 2024 | 19.38% |
| Mar 31, 2024 | 18.54% |
| Dec 31, 2023 | 21.62% |
| Sep 30, 2023 | 18.97% |
| Jun 30, 2023 | 19.32% |
| Mar 31, 2023 | 15.38% |
| Dec 31, 2022 | 15.65% |
| Sep 30, 2022 | 18.04% |
| Jun 30, 2022 | 17.18% |
| Mar 31, 2022 | 10.46% |
| Dec 31, 2021 | 17.42% |
| Sep 30, 2021 | 13.80% |
| Jun 30, 2021 | 17.05% |
| Mar 31, 2021 | 11.61% |
| Dec 31, 2020 | 17.57% |
| Sep 30, 2020 | 22.99% |
| Jun 30, 2020 | -0.72% |
| Mar 31, 2020 | 17.70% |
| Dec 31, 2019 | 22.85% |
| Sep 30, 2019 | 17.51% |
| Jun 30, 2019 | 16.79% |
| Mar 31, 2019 | 15.02% |
| Dec 31, 2018 | 18.39% |
| Sep 30, 2018 | 17.77% |
| Jun 30, 2018 | 20.23% |
| Mar 31, 2018 | 18.24% |
| Dec 31, 2017 | 20.57% |
| Sep 30, 2017 | 17.47% |
| Jun 30, 2017 | 16.67% |
| Mar 31, 2017 | 18.82% |
| Dec 31, 2016 | 21.22% |
| Sep 30, 2016 | 17.15% |
| Jun 30, 2016 | 17.61% |
| Mar 31, 2016 | 20.80% |
| Dec 31, 2015 | 23.87% |
| Sep 30, 2015 | 15.62% |
| Jun 30, 2015 | 17.64% |
| Mar 31, 2015 | 17.07% |
| Dec 31, 2014 | 17.88% |
| Sep 30, 2014 | 18.84% |
| Jun 30, 2014 | 8.34% |
| Mar 31, 2014 | 5.68% |
| Dec 31, 2013 | 17.42% |
| Sep 30, 2013 | 6.97% |
| Jun 30, 2013 | 13.11% |
| Mar 31, 2013 | 17.63% |
| Dec 31, 2012 | 15.83% |
| Sep 30, 2012 | 21.93% |
| Jun 30, 2012 | 21.13% |
| Mar 31, 2012 | 22.03% |
| Dec 31, 2011 | 18.87% |
| Sep 30, 2011 | 21.86% |
| Jun 30, 2011 | 19.60% |
| Mar 31, 2011 | 20.99% |
| Dec 31, 2010 | 19.35% |
| Sep 30, 2010 | 26.64% |
| Jun 30, 2010 | 25.49% |
| Mar 31, 2010 | 24.81% |
| Dec 31, 2009 | 28.00% |
| Sep 30, 2009 | 18.84% |
| Jun 30, 2009 | 23.85% |
| Mar 31, 2009 | 23.68% |